title: Dose-response clarification in early drug development.
authors.affiliation: University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow, UK.
authors.forename: P A
authors.initials: PA
authors.lastname: Meredith
authors.forename: H L
authors.initials: HL
authors.lastname: Elliott
authors.forename: R
authors.initials: R
authors.lastname: Donnelly
authors.forename: J L
authors.initials: JL
authors.lastname: Reid
mesh_terms: D000959:Antihypertensive Agents / Q000493:pharmacokinetics; D001794:Blood Pressure / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D017292:Doxazosin; D004656:Enalapril / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D009543:Nifedipine / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D011224:Prazosin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D004656:Enalapril; D009543:Nifedipine; D017292:Doxazosin; D011224:Prazosin